Connexion
Mot de passe oublié Pas encore de compte ?

SANOFI

SAN - FR0000120578 SRD PEA PEA-PME
86.280 € +0.02 % Temps réel Euronext Paris

Sanofi : Sanofi in agreement with Janssen to develop E. coli the vaccine candidate

mardi 3 octobre 2023 à 07h44
Sanofi in agreement with Janssen to develop E. coli the vaccine candidate

PARIS (Reuters) - Sanofi on Tuesday announced it had reached an agreement with Janssen, a part of Johnson & Johnson, to develop and commercialize a vaccine candidate for extra-intestinal pathogenic E.coli.

Under the terms of the deal, both parties will co-fund current and future research and development costs. Sanofi will pay 5 million upfront to Janssen, followed by development and commercial milestones.

(Reporting by Tassilo Hummel; Editing by Benoit Van Overstraeten)

Copyright © 2023 Thomson Reuters

Vous suivez cette action ?

Recevez toutes les infos sur SANOFI en temps réel :

Par « push » sur votre mobile grâce à l’application BFM Bourse


Par email

Forum suspendu temporairement
Portefeuille Trading
+336.80 % vs +55.09 % pour le CAC 40
Performance depuis le 28 mai 2008

Newsletter bfm bourse

Recevez gratuitement chaque matin la valeur du jour